Suppr超能文献

慢性荨麻疹的 H1 和 H2 抗组胺药联合治疗

Combined H1 and H2 antihistamine therapy in chronic urticaria.

作者信息

Monroe E W, Cohen S H, Kalbfleisch J, Schulz C I

出版信息

Arch Dermatol. 1981 Jul;117(7):404-7.

PMID:6114712
Abstract

Chronic urticaria is a frustrating problem for the patient and the physician. The cause is usually undetermined, and the therapy is directed toward controlling symptoms. Recent evidence that human skin blood vessels possess H2 receptors, as well as the commonly recognized H1 receptors, suggests a possible reason for the frequent failure of H1 antihistamines in controlling this disorder. Eighteen patients with refractory chronic idiopathic urticaria participated in a double-blind, cross-over study to evaluate the efficacy of combined H1 (hydroxyzine hydrochloride) and H2 (cimetidine) antihistamines vs H1 antihistamines alone. This study indicates that combined H1 and H2 antihistamine therapy is statistically more effective than H1 antihistamines alone in controlling the symptoms of chronic urticaria.

摘要

慢性荨麻疹对患者和医生来说都是一个令人沮丧的问题。病因通常不明,治疗旨在控制症状。最近有证据表明,人类皮肤血管除了拥有普遍认可的H1受体外,还拥有H2受体,这提示了H1抗组胺药在控制这种疾病时频繁失效的一个可能原因。18例难治性慢性特发性荨麻疹患者参与了一项双盲交叉研究,以评估联合使用H1(盐酸羟嗪)和H2(西咪替丁)抗组胺药与单独使用H1抗组胺药的疗效。这项研究表明,在控制慢性荨麻疹症状方面,联合使用H1和H2抗组胺药在统计学上比单独使用H1抗组胺药更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验